Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides

• Main Authors: Debra L Breneman (Author), Timothy J Storer (Author), John C Breneman (Author), Diya F Mutasim (Author)
• Format: Book
• Published: Dove Medical Press, 2008-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Debra L Breneman1, Timothy J Storer2, John C Breneman3, Diya F Mutasim41University of Cincinnati Medical Center, Dept of Dermatology, Cincinnati, Ohio, USA; 2Smith Clinic, Delaware, Ohio, USA; 3University of Cincinnati Medical Center, Dept of Radiology, Division of Radiation Oncology, Cincinnati, Ohio, USA; 4University of Cincinnati Medical Center, Dept of Dermatology, Cincinnati, Ohio, USAAbstract: Methotrexate-induced cutaneous ulceration has rarely been reported in patients with mycosis fungoides. We report 4 patients with mycosis fungoides who developed cutaneous ulceration as an initial manifestation of methotrexate toxicity. Methotrexate dose at the time of ulceration ranged from 10–60 mg. All 4 patients were erythrodermic, which may have predisposed them to this toxic effect. It is important to recognize cutaneous ulceration as an uncommon, but potentially serious, side effect of methotrexate in these patients, and to differentiate it from ulceration due to progressive lymphoma.Keywords: mycosis fungoides, methotrexate, ulceration, cutaneous T-cell lymphoma, toxicity

Item Description

1176-6336
1178-203X